What if you'd held CSBR?
A $1,000 investment in Champions Oncology, Inc. (CSBR) at the month-end close of 2007-02 would be worth $1,243 at the close of 2026-09 — +24.3% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $7,950.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2007
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2007 | $1,000 | — |
| 2008 | $771 | -22.9% |
| 2009 | $571 | -25.9% |
| 2010 | $643 | +12.5% |
| 2011 | $536 | -16.7% |
| 2012 | $214 | -60.0% |
| 2013 | $857 | +300.0% |
| 2014 | $357 | -58.3% |
| 2015 | $213 | -40.5% |
| 2016 | $151 | -29.1% |
| 2017 | $231 | +53.4% |
| 2018 | $465 | +101.3% |
| 2019 | $496 | +6.7% |
| 2020 | $642 | +29.5% |
| 2021 | $498 | -22.5% |
| 2022 | $268 | -46.1% |
| 2023 | $335 | +24.6% |
| 2024 | $510 | +52.5% |
| 2025 | $411 | -19.4% |
| 2026 | $311 | -24.5% |
Best and worst month-end to buy
The best single month-end close to have bought CSBR was 2016-10 ($1.58): $1,000 then is $3,304 today. The worst was 2013-09 ($21.00): $1,000 then is $249.
FAQ
What would $1,000 in CSBR be worth today?
A $1,000 investment in Champions Oncology, Inc. (CSBR) at the start of 2007 would be worth about $1,243 today, a total return of +24.3%. Dividends are reinvested in these figures.
What were the best and worst years for CSBR?
Champions Oncology, Inc. (CSBR)'s strongest calendar year since 2007 was 2013, a +300.0% return — $1,000 held through that year became about $4,000 by year-end. Its weakest year was 2012, at -60.0%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in CSBR have grown?
Investing $100 at the end of every month since 2007-02 would have grown to about $19,737 on $23,600 invested.
Did CSBR beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $7,950. CSBR trailed the S&P 500 by +84.4% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Champions Oncology, Inc. (CSBR) historical total-return data from 2007-02 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.